Volume 67, Issue 4, Pages 1489-1499 (April 2005) Renal replacement therapy for diabetic end-stage renal disease: Data from 10 registries in Europe (1991–2000)  Paul C.W. Van Dijk, Kitty J. Jager, Benedicte Stengel, Carola Gronhagen-Riska, Terry G. Feest, J. Douglas Briggs  Kidney International  Volume 67, Issue 4, Pages 1489-1499 (April 2005) DOI: 10.1111/j.1523-1755.2005.00227.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Trends in incidence of RRT for the treatment of type 1 (A) and type 2 (B) DN patients by gender and age category. The numbers on the righthand side indicate the incidence per million age and gender related population for each group for the year 2000. Kidney International 2005 67, 1489-1499DOI: (10.1111/j.1523-1755.2005.00227.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Age- and gender-adjusted incidence of type 1 (A) and type 2 (B) DN (pmp) by country and year.*P < 0.05 for the within group trend (mean % annual change). Kidney International 2005 67, 1489-1499DOI: (10.1111/j.1523-1755.2005.00227.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Access to transplantation by age, diabetic status, and time period. NA, not assessed because the number of transplant recipients was too low. Kidney International 2005 67, 1489-1499DOI: (10.1111/j.1523-1755.2005.00227.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Two-year death rates among dialysis patients with diabetic ESRD versus nondiabetic ESRD (adjusted to the age, gender, and country distribution of incident patients in 1999). Kidney International 2005 67, 1489-1499DOI: (10.1111/j.1523-1755.2005.00227.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 The 2-year death rates for first transplant recipients between patients with type 1 DN and those in the nondiabetic group in 2 time periods, 1991–1994 and 1995–1998 are compared (A). Adjusted hazard ratios (AHR) for the same time periods for 4 age groups of patients with type 1 DN receiving their first transplant in 1999 are shown (B). They are compared with nondiabetic recipients who are the reference group with a AHR of 1. In both figures we adjusted to the age, gender, country, and donor type distribution of incident patients in 1999. Kidney International 2005 67, 1489-1499DOI: (10.1111/j.1523-1755.2005.00227.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Death due to cardiac causes versus other causes in diabetic and nondiabetic ESRD (1991–2000). Kidney International 2005 67, 1489-1499DOI: (10.1111/j.1523-1755.2005.00227.x) Copyright © 2005 International Society of Nephrology Terms and Conditions